Xiaodong Ling
Overview
Explore the profile of Xiaodong Ling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu B, Zhao X, He H, Zhou L, Fan Y, Chai X, et al.
Ecotoxicol Environ Saf
. 2025 Mar;
292:117990.
PMID: 40023998
Human are widely exposed to polycyclic aromatic hydrocarbon (PAHs), but existing evidence about exposure to urinary PAHs metabolites for pulmonary health in children and adolescents is limited. Our aim was...
2.
Ma J, Zhang P, Wang Y, Lu M, Cao K, Wei S, et al.
Int Immunopharmacol
. 2024 Sep;
142(Pt B):113264.
PMID: 39340992
Non-small cell lung cancer (NSCLC) is a primary cause of cancer-related mortality on a global scale. Research increasingly shows that long non-coding RNAs (lncRNAs) play crucial regulatory roles and serve...
3.
Ling X, Zhang L, Fang C, Liang H, Ma J
Cancer Cell Int
. 2024 Sep;
24(1):310.
PMID: 39252014
Background: Phosphofructokinase P (PFKP) is a key rate-limiting enzyme in glycolysis, playing a crucial role in various pathophysiological processes. However, its specific function in tumors remains unclear. This study aims...
4.
Gu M, Wang H, Chen G, Yu A, Dang W, Ling X
Sci Rep
. 2024 Sep;
14(1):20643.
PMID: 39232177
To reduce the number of casualties in explosion accidents, blast-resistant shelters can be used to protect personnel in high-risk areas of petrochemical processing plants. In this work, the deformation behaviours...
5.
Yin H, Wang Y, Wang S, Zhang S, Ling X, Han T, et al.
Int J Surg
. 2024 Aug;
110(8):4767-4774.
PMID: 39143708
Background: Although previous research has indicated a correlation between smoking and the mortality rate in patients with lung cancer, the impact of early life factors on this relationship remains unclear...
6.
Ling X, Qi C, Cao K, Lu M, Yang Y, Zhang J, et al.
Cell Death Discov
. 2024 Apr;
10(1):203.
PMID: 38688909
We previously reported lncRNA HAR1A as a tumor suppressor in non-small cell lung cancer (NSCLC). However, the delicate working mechanisms of this lncRNA remain obscure. Herein, we demonstrated that the...
7.
Wang X, Liang H, Tang X, Ling X, Yang Y
Heliyon
. 2024 Mar;
10(5):e27071.
PMID: 38463784
Background: Lung cancer metastasis to the brain presents significant clinical challenges. Therefore, elucidating its underlying mechanisms and characterizing its transcriptomic landscape is essential for developing therapeutic interventions. Methods: We analyzed...
8.
Cao K, Zhu J, Lu M, Zhang J, Yang Y, Ling X, et al.
EBioMedicine
. 2023 Dec;
99:104920.
PMID: 38101299
Background: Oesophageal squamous cell carcinoma (ESCC) is a lethal malignancy. Immune checkpoint inhibitors (ICIs) showed great clinical benefits for patients with ESCC. We aimed to construct a model predicting prognosis...
9.
Yang Y, Zhang J, Meng H, Ling X, Wang X, Xin Y, et al.
Int J Surg
. 2023 Dec;
110(3):1430-1440.
PMID: 38051925
Background: Neoadjuvant administration of immune checkpoint inhibitors (ICIs) combined with chemotherapy demonstrated promising efficacy and manageable safety in locally advanced esophageal squamous cell carcinoma (ESCC). This prospective, single-arm, phase 2...
10.
Zhang J, Xin Y, Ling X, Liang H, Zhang L, Fang C, et al.
Hum Cell
. 2023 Nov;
37(1):245-257.
PMID: 37993750
Nucleoporin 93 (NUP93) is an important component of the nuclear pore complex, exhibiting pro-tumorigenic properties in some cancers. However, its function in esophageal squamous cell carcinoma (ESCC) has not been...